Search results
Is AbbVie Stock a Buy Now?
Motley Fool· 6 months agoLeading healthcare company AbbVie (NYSE: ABBV) appears to be hungry for deals to help it diversify its revenue streams. One example of this came in 2020...
Pfizer to raise $31 billion for Seagen takeover in largest debt offering
Reuters via Yahoo Finance· 1 year agoThe company struck a $43 billion deal in March to acquire Seagen and its targeted cancer therapies...
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago
Zacks via Yahoo Finance· 6 months agoHow much a stock's price changes over time is important for most investors, since price performance...
Bausch + Lomb’s CEO Is Selling His Waterfront Miami Beach Mansion for $19.5 Million
Robb Report via Yahoo News· 8 months agoIf you’ve been eyeing what’s soon-to-be the only gated section of the Venetian Islands, a waterfront...
Brent Saunders to return as Bausch + Lomb CEO
Reuters via Yahoo Finance· 1 year ago(Reuters) -Bausch + Lomb Corp on Wednesday named Brent Saunders, the former chief executive officer of Allergan, as its CEO and chairman of board,...
3 Reasons Berkshire Hathaway's Bearishness May Be Warranted
Motley Fool via Yahoo Finance· 4 months agoBerkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), the conglomerate led by legendary investor Warren...
AbbVie Results Fall But The Drop Isn't As Severe As Expected; Shares Climb
Investor's Business Daily· 11 months agoDrug maker AbbVie on Thursday reported second-quarter profit and sales that fell from a year earlier...
If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today
Motley Fool· 1 year agoAbbVie (NYSE: ABBV) is a top healthcare company that's worth nearly $290 billion. It has a diverse...
Relative Strength Found Within These 3 Medical Stocks
Zacks via Yahoo Finance· 2 years agoThe Zacks Medical sector has displayed relative strength and modestly outperformed the S&P 500 over...
Rick Gonzalez, longtime AbbVie CEO, to step down in July
BioPharma Dive via Yahoo Finance· 4 months agoAbbVie CEO Richard Gonzalez, the only chief executive in the big drugmaker’s history, will retire on...
